Bilateral undescended testes with intraabdominal non seminomatous germ cell tumor – a rare clinical challenge
DOI:
https://doi.org/10.18203/2320-6012.ijrms20263124Keywords:
Cryptorchidism, Intraabdominal mass, Non seminomatous germ cell tumor, Testicular tumor, Undescended testesAbstract
Cryptorchidism is the most common congenital anomaly of the male genitalia, with nearly 72-77% of undescended testes located in the inguinal canal. Among malignancies arising in undescended testes, seminoma is the most frequent type, accounting for approximately 50-60% of cases. Tumors arising from intra-abdominal testes may grow to considerable sizes before detection, and delayed diagnosis often results in advanced-stage disease at presentation. We report a case of bilateral cryptorchidism in a young male who presented with vague lower abdominal pain, without any prior history of abdominal swelling or distension. The patient had noticed an empty scrotum since around 10 years of age but did not seek medical evaluation due to social stigma. Eventually, at the age of 21 years, he developed a large intra-abdominal non-seminomatous germ cell tumor arising from an undescended testis. The patient subsequently underwent an exploratory laparotomy with right radical orchidectomy and left orchidectomy, followed by advice to undergo adjuvant chemotherapy and regular follow-up.
References
Looijenga LH, Van der Kwast TH, Grignon D, Egevad L, Kristiansen G, et al. Report from the International Society of Urological Pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: IV: current and future utilization of molecular-genetic tests for testicular germ cell tumors. Am J Surg Pathol. 2020;44:66-79.
Lip SZ, Murchison LE, Cullis PS, Govan L, Carachi R. A meta-analysis of the risk of boys with isolated cryptorchidism developing testicular cancer in later life. Arch Dis Child. 2013;98:20-6.
Docimo SG, Silver RI, Cromie W. The undescended testicle: diagnosis and management. Am Fam Physician. 2000;62(9):2037-48.
Dieckmann KP, Pichlmeier U. Clinical epidemiology of testicular germ cell tumors. World J Urol. 2004;22(1):2-14.
Wood HM, Elder JS. Cryptorchidism and testicular cancer: separating fact from fiction. J Urol. 2009;181(2):452-61.
Akre O, Pettersson A, Richiardi L. Risk of contralateral testicular cancer among men with unilaterally undescended testis: a meta-analysis. Int J Cancer. 2009;124(3):687-9.
Luz MA, Kotb AF, Aldousari S, Brimo F, Tanguay S, Kassouf W, et al. Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor. World J Surg Oncol. 2010;8:97.
Donohue JP, Zachary JM, Maynard BR. Distribution of nodal metastases in nonseminomatous testis cancer. J Urol. 1982;128(2):315-20.
Koschel SG, Wong LM. Radical inguinal orchidectomy: the gold standard for initial management of testicular cancer. Transl Androl Urol. 2020;9(6):3094-102.
Nauman M, Leslie SW. Nonseminomatous Testicular Tumors. StatPearls. Treasure Island (FL): StatPearls Publishing; 2023.
Chakiryan NH, Dahmen A, Cucchiara V, Briganti A, Montorsi F, Salonia A, et al. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review. J Urol. 2021;205(6):1569-76.
Ahluwalia P, Gautam G. Current Concepts in Management of Stage I NSGCT. Indian J Surg Oncol. 2017;8(1):51-8.
Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, et al. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part I. Eur Urol. 2008;53(3):478-96.